Release Date: 13/06/19 13:38 Summary: Change in substantial holding from CBA Price Sensitive: No Download Document 123.71KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%